CAG
30
4
QCOM
48
-7
DNB
78
6
ACN
47
-2
HAS
30
2
UA
45
-3
HUM
48
6
HCP
58
4
EXPE
88
2
BIIB
26
2
MTCH
37
7
FMC
31
5
HSIC
54
-3
MRK
22
3
LLY
39
9
HRL
39
15
GRMN
62
-3
DHI
48
3
AMAT
36
5
OXY
40
3
CAG
30
4
QCOM
48
-7
DNB
78
6
ACN
47
-2
HAS
30
2
UA
45
-3
HUM
48
6
HCP
58
4
EXPE
88
2
BIIB
26
2
MTCH
37
7
FMC
31
5
HSIC
54
-3
MRK
22
3
LLY
39
9
HRL
39
15
GRMN
62
-3
DHI
48
3
AMAT
36
5
OXY
40
3
Financhill
Back

Vanda Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34

VNDA
Vanda Pharmaceuticals

Last Price:
4.94
Seasonality Move:
5.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Vanda Pharmaceuticals Price Quote

$4.94
+0.04 (+0.82%)
(Updated: November 21, 2024 at 5:55 PM ET)

Vanda Pharmaceuticals Key Stats

Sell
34
Vanda Pharmaceuticals (VNDA) is a Sell
Day range:
$4.83 - $4.94
52-week range:
$3.44 - $6.75
Dividend yield:
0%
P/E ratio:
124.50
P/S ratio:
1.51
P/B ratio:
0.54%
Volume:
396.1K
Avg. volume:
750.9K
1-year change:
36.87%
Market cap:
$290.4M
Revenue:
$192.6M
EPS:
$-0.28

How Much Does Vanda Pharmaceuticals Make?

Is Vanda Pharmaceuticals Growing As A Company?

  • What Is Vanda Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.23%
  • What Is Vanda Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Vanda Pharmaceuticals Stock Price Performance

What Is Vanda Pharmaceuticals 52-Week High & Low?

Vanda Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vanda Pharmaceuticals?

Is Vanda Pharmaceuticals Cash Flow Positive?

  • What Is VNDA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17.7M
  • What Is Vanda Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Vanda Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$65.2M

Vanda Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    VNDA return on invested capital is -3.02%
  • What Is Vanda Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -2.53%
  • What Is VNDA Return On Equity?
    ROE is a measure of profitability and is -3.02%

Vanda Pharmaceuticals Earnings Date & Stock Price

Vanda Pharmaceuticals Competitors

  • Who Are Vanda Pharmaceuticals's Competitors?
    Below is a list of companies who compete with Vanda Pharmaceuticals or are related in some way:
    • Black Diamond Therapeutics Inc (BDTX)
    • Edgewise Therapeutics Inc (EWTX)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Zevra Therapeutics Inc (ZVRA)

Vanda Pharmaceuticals Dividend Yield

Vanda Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 22.76% -3.06%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 10.43
Upside from Last Price: 112.81%

Major Shareholders

  • How many VNDA shares are owned by institutional investors?
    66.9M VNDA shares are owned by institutional investors
  • How many VNDA shares are owned by insiders?
    4M VNDA shares are owned by insiders